NUT2

1. NUT2 decreases homocysteine in humans.

   “Significant reductions in homocysteine and lower fasting insulin concentrations were observed with NUT2.”

   Human trial12 weeks

   Effects of a Multi-Component Nutraceutical (NUT2) on the Lipid Profile in Adults with Low-to-Moderate Cardiovascular Risk: A Randomized Placebo-Controlled Trial

   Nutrients·12 Aug 2026

More on Homocysteine

1. NUT2 decreases total cholesterol in humans (-26 mg/dL (95% CI -36 to -17; p < 0.001)).

   “Total cholesterol was also significantly reduced (corrected difference -26 mg/dL, 95% CI -36 to -17; p < 0.001).”

   Human trial12 weeks

   Effects of a Multi-Component Nutraceutical (NUT2) on the Lipid Profile in Adults with Low-to-Moderate Cardiovascular Risk: A Randomized Placebo-Controlled Trial

   Nutrients·12 Aug 2026

More on Total cholesterol

1. NUT2 decreases LDL-C in humans (-23 mg/dL (95% CI -29 to -16; p < 0.001)).

   “the baseline-corrected between-group difference was -23 mg/dL (95% CI -29 to -16; p < 0.001)”

   Human trial12 weeks

   Effects of a Multi-Component Nutraceutical (NUT2) on the Lipid Profile in Adults with Low-to-Moderate Cardiovascular Risk: A Randomized Placebo-Controlled Trial

   Nutrients·12 Aug 2026

More on LDL-C

1. NUT2 lowers the risk of metabolic syndrome in humans (13.3% vs 37.8% (p = 0.008)).

   “Metabolic syndrome prevalence was 13.3% with NUT2 versus 37.8% with placebo at Week 12 (p = 0.008)”

   Human trial12 weeks

   Effects of a Multi-Component Nutraceutical (NUT2) on the Lipid Profile in Adults with Low-to-Moderate Cardiovascular Risk: A Randomized Placebo-Controlled Trial

   Nutrients·12 Aug 2026

More on Metabolic syndrome